News

Glenmark Pharmaceuticals Ltd. on Tuesday said it has launched the lung cancer treatment drug Tevimbra in India, following the ...
Glenmark Pharmaceuticals launches Tevimbra, a new lung cancer treatment drug, in India. This marks Glenmark's entry into ...
Neoadjuvant osimertinib results in a 15% major pathological response rate in resectable EGFR-mutant lung cancer. ... Lv C, Fang W, Wu N, et al: Osimertinib as neoadjuvant therapy in patients with EGFR ...
The FDA has approved AstraZeneca and Daiichi Sankyo's Datroway (Datopotamab deruxtecan) for adults with NSCLC.